It is a comparison between two formulations of the same active compound, each with distinct advantages depending on the intended route of administration and therapeutic goals
Journal of Alternative and Complementary Medicine
BPC57 was moved to a category 2 list in late 2024, which means that the FDA does not recommend compounding it, but some compounding pharmacies have found ways to re-label it as a different peptide, such as PDA or pentadecapeptide arginate, which is essentially the same thing 10m40s
Peptide clearance depends on: Half-life (short vs long-acting compounds) Route of administration (subcutaneous vs intramuscular) Structural modifications (e.g., PEGylation or DAC binding) Metabolic rate and enzymatic activity Short-acting peptides like GHRP-6, Ipamorelin, and Tesamorelin are typically cleared within 2448 hours
With an aim to maintain its sterility over time, it is crucial to learn how to store bacteriostatic water after opening